دورية أكاديمية
Medication-Related Readmissions: Documentation of the Medication Involved and Communication in the Care Continuum.
| العنوان: | Medication-Related Readmissions: Documentation of the Medication Involved and Communication in the Care Continuum. |
|---|---|
| المؤلفون: | Lee ZY; Department of Clinical Pharmacy, OLVG, Amsterdam, Netherlands., Uitvlugt EB; Department of Clinical Pharmacy, OLVG, Amsterdam, Netherlands., Karapinar-Çarkit F; Department of Clinical Pharmacy, OLVG, Amsterdam, Netherlands. |
| المصدر: | Frontiers in pharmacology [Front Pharmacol] 2022 Mar 21; Vol. 13, pp. 824892. Date of Electronic Publication: 2022 Mar 21 (Print Publication: 2022). |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: [Lausanne : Frontiers Media] |
| مستخلص: | Background: Of all readmissions, 21% are medication-related readmissions (MRRs). However, it is unknown whether MRRs are recognized at the time of readmission and are communicated in the care continuum. Objectives: To identify the prevalence of MRRs that contain a documentation on the medication involved (and therefore are regarded as recognized), and the proportion of communicated MRRs. Setting : The study was performed in a teaching hospital. Methods: In a previous study, a multidisciplinary team of physicians and pharmacists assessed the medication-relatedness, the medication involved and preventability of unplanned readmissions from seven departments. In the current cross-sectional study, two pharmacy team members evaluated the patient records independently. An MRR was regarded as recognized when the medication involved was documented in patient records. An MRR was regarded as communicated to the patient and/or the next healthcare provider when the medication involved or a description was mentioned in discharge letters or discharge prescriptions. The relationship between documented MRRs and whether the MRR was preventable as well as the relationship between (un)documented MRRs and the length of stay (LOS) were assessed. Descriptive data analysis was used. Results: Of 181 included MRRs, 72 (40%) were deemed preventable by the multidisciplinary team. For 159 of 181 MRRs (88%), a documentation on the medication involved was present. Of 159 documented MRRs, 93 (58%) were communicated to patients and/or caregivers, 137 (86%) to the general practitioner, and 4 (3%) to the community pharmacy. The medication involved was documented less often for potentially preventable MRRs than for non-preventable MRRs (78 vs. 95%; p = 0.002). The LOS was longer for MRRs where the medication involved was undocumented (median 8 vs. 5 days; p = 0.062). Conclusion: The results of this study imply that MRRs are not always recognized, which could impact patients' well-being. In this study an increased LOS was observed with unrecognized MRRs. Communication of MRRs to the patients and/or the next healthcare providers should be improved. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2022 Lee, Uitvlugt and Karapinar-Çarkit.) |
| References: | BMC Nurs. 2018 Mar 12;17:9. (PMID: 29563855) Health Expect. 2020 Feb;23(1):212-219. (PMID: 31733100) PLoS One. 2020 Apr 2;15(4):e0229940. (PMID: 32240185) Qual Saf Health Care. 2008 Feb;17(1):71-5. (PMID: 18245223) JAMA Intern Med. 2016 Apr;176(4):484-93. (PMID: 26954564) Arch Intern Med. 2006 Aug 14-28;166(15):1666-7. (PMID: 16908802) Pharmacoepidemiol Drug Saf. 2015 May;24(5):495-503. (PMID: 25683383) Int J Evid Based Healthc. 2016 Sep;14(3):113-22. (PMID: 26886682) Sci Rep. 2021 Oct 11;11(1):20172. (PMID: 34635681) An Med Interna. 2007 Mar;24(3):113-9. (PMID: 17590131) Front Pharmacol. 2021 Apr 13;12:567424. (PMID: 33927612) Int J Clin Pharm. 2021 Aug;43(4):839-846. (PMID: 33201489) BMC Health Serv Res. 2019 Mar 29;19(1):204. (PMID: 30925880) BMJ Qual Saf. 2018 Sep;27(9):683-690. (PMID: 29146680) BMC Health Serv Res. 2010 Nov 17;10:311. (PMID: 21080970) Acad Emerg Med. 2005 Mar;12(3):197-205. (PMID: 15741581) PLoS One. 2009;4(2):e4439. (PMID: 19209224) Int J Clin Pharm. 2016 Oct;38(5):1172-81. (PMID: 27473712) Medicines (Basel). 2021 Aug 27;8(9):. (PMID: 34564088) Glob J Health Sci. 2015 Dec 18;8(8):54510. (PMID: 27045415) J Am Geriatr Soc. 2018 Mar;66(3):602-608. (PMID: 29468640) N Engl J Med. 2009 Apr 2;360(14):1418-28. (PMID: 19339721) Inquiry. 2019 Jan-Dec;56:46958019860386. (PMID: 31282282) Cureus. 2020 Jul 21;12(7):e9308. (PMID: 32839677) BMC Geriatr. 2020 Sep 7;20(1):332. (PMID: 32894056) BMJ Open Qual. 2021 Jan;10(1):. (PMID: 33495196) |
| فهرسة مساهمة: | Keywords: hospital readmissions; length of stay; medication-related problems; preventability; quality of heathcare |
| تواريخ الأحداث: | Date Created: 20220407 Latest Revision: 20220408 |
| رمز التحديث: | 20221213 |
| مُعرف محوري في PubMed: | PMC8978797 |
| DOI: | 10.3389/fphar.2022.824892 |
| PMID: | 35387329 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2022.824892 |